FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

348445008: Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3700063017 Hyoscine hydrobromide 150 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3700064011 Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3700066013 Scopolamine hydrobromide 150 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hyoscine hydrobromide 150 microgram oral tablet Is a Scopolamine hydrobromide false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Is a Hyoscine false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Scopolamine (substance) false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Is a Hyoscine hydrobromide false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Scopolamine hydrobromide (substance) false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Is a Scopolamine hydrobromide false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Is a Hyoscine-containing product in oral dose form false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Scopolamine hydrobromide (substance) false Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Scopolamine hydrobromide (substance) true Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has presentation strength numerator value 150 false Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mcg true Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has presentation strength denominator value un false Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has presentation strength numerator value 0.15 false Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Scopolamine hydrobromide (substance) true Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Count of base of active ingredient un false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Is a Hyoscine only product in oral dose form true Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Plays role Antiemetic therapeutic role (role) false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start